Assenagon Asset Management
RGNX icon

Assenagon Asset Management’s Regenxbio RGNX Stock Holding History

Assenagon Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Sell
169,279
-811,332
-83% -$6.73M ﹤0.01% 847
2026
Q1 		$8.22M Sell
980,611
-179,769
-15% -$1.89M 0.01% 498
2025
Q4 		$16.7M Buy
1,160,380
+454,977
+64% +$5.67M 0.02% 397
2025
Q3 		$6.81M Buy
705,403
+132,942
+23% +$1.18M 0.01% 561
2025
Q2 		$4.7M Sell
572,461
-712
-0.1% -$5.96K 0.01% 583
2025
Q1 		$4.1M Sell
573,173
-283,399
-33% -$2.11M 0.01% 574
2024
Q4 		$6.62M Buy
856,572
+296,700
+53% +$2.79M 0.01% 626
2024
Q3 		$5.87M Sell
559,872
-256,512
-31% -$3.13M 0.01% 668
2024
Q2 		$9.55M Buy
816,384
+588,773
+259% +$9.16M 0.02% 441
2024
Q1 		$4.8M Buy
227,611
+120,929
+113% +$2.15M 0.01% 620
2023
Q4 		$1.91M Buy
+106,682
New +$1.88M 0.01% 944
2022
Q3 		– Sell
-363,138
Closed -$8.97M – 1515
2022
Q2 		$8.97M Hold
363,138
– – 0.03% 393
2022
Q1 		$12.1M Buy
363,138
+85,438
+31% +$2.37M 0.03% 322
2021
Q4 		$9.08M Buy
277,700
+139,947
+102% +$4.77M 0.03% 351
2021
Q3 		$5.78M Buy
+137,753
New +$4.96M 0.02% 390
2020
Q3 		– Sell
-46,292
Closed -$1.71M – 1317
2020
Q2 		$1.71M Sell
46,292
-21,200
-31% -$790K 0.01% 649
2020
Q1 		$2.19M Buy
+67,492
New +$2.81M 0.02% 340

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Assenagon Asset Management's RGNX Position: Q2 2026 in Review

Assenagon Asset Management reduced its Regenxbio (RGNX) stake by 83% in Q2 2026, selling an estimated $6.73M and leaving 169,279 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #847.

Assenagon Asset Management first reported a position in RGNX in Q1 2020 and has held it in 17 quarters since. The position peaked at $16.7M in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Assenagon Asset Management held 169,279 shares of Regenxbio worth $2.03M as of Q2 2026.
  • Assenagon Asset Management sold 811,332 Regenxbio shares in Q2 2026, an estimated $6.73M.
  • Regenxbio made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #847 holding.
  • Assenagon Asset Management first reported a position in Regenxbio in Q1 2020 and has held it in 17 quarters since.
  • Assenagon Asset Management's Regenxbio position peaked at $16.7M in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.